Immune imitation of tumor progression after anti-CD19 chimeric antigen receptor T cells treatment in aggressive B-cell lymphoma

We present three patients with aggressive non-Hodgkin’s B-cell lymphoma (NHL) who received anti-CD19 chimeric antigen receptor T (CAR T) cells therapy after failure of several lines of chemotherapy that developed pseudo-progression. One-week clinical and radiological findings were consistent with tu...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Bone Marrow Transplant
Main Authors: Danylesko, Ivetta, Shouval, Roni, Shem-Tov, Noga, Yerushalmi, Ronit, Jacoby, Elad, Besser, Michal J., Shimoni, Avichai, Davidson, Tima, Beider, Katia, Mevorach, Dror, Fried, Shalev, Nagler, Arnon, Avigdor, Abraham
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8113054/
https://ncbi.nlm.nih.gov/pubmed/33268830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-020-01156-y
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares